Project description
Innovative training in ion mobility mass spectrometry
The Ion Mobility-High Resolution Mass Spectrometry (IM-HRMS) platform, a powerful analytical tool, holds potential across various fields. However, challenges arise in data collection, analysis, and reporting. Achieving harmonisation involves pushing the boundaries of instrumentation and enhancing our fundamental understanding and applications. The MSCA-funded MobiliTraIN project will train 10 doctoral candidates in IM-HRMS. Their focus will be on developing new methods for biopharmaceutical development, biological omics studies, and contaminant screening. They will acquire a unique skill set, transforming them into leading experts in ion mobility. This expertise will not only advance their careers, but also contribute to supporting Europe's innovation capacity. The project’s overall goal is to fully realise the potential of IM-HRMS in ensuring public health safety.
Objective
Ion mobility-high resolution mass spectrometry (IM-HRMS) is the next-generation analytical platform in research and industry. Unlocking its full potential across applications as varied as biotherapeutics, environment and food safety requires not only pushing back the frontiers of instrumentation, fundamental understanding and applications – but harmonisation is essential. To achieve this, current shortcomings in data collection, analysis and reporting across instrument types, laboratories and research areas need to be scrutinised and overcome.
The MobiliTraIN Doctoral Network will form 13 Doctoral Candidates (DCs) who will bring a new fundamental understanding of IM-HRMS, provide reference materials and guidelines for standardisation, develop state-of-the-art methods for the application of IM-HRMS in biopharmaceutical development, biological ‘omics studies, and nontarget screening of contaminants, and lay the foundations for IM-HRMS adoption in industry. Through an interdisciplinary research programme, including an open science approach and training in technical, business and transferable skills, the MobiliTraIN DCs will become leading experts in ion mobility with a unique skill set to successfully advance their careers while supporting Europe’s innovation capacity.
Building on existing collaborations and research excellence covering the entire innovation chain of IM-HRMS development and application, MobiliTraIN unites 10 academic institutions, 3 leading instrumentation companies, 1 regulatory agency, 1 pharma industry leader and 5 SMEs from 8 countries. With complementary expertise, know-how and mentoring experience, our consortium is ideally suited to unveil the potential of IM-HRMS as a key technology for safer therapeutics, better understanding of complex disease progression and improved monitoring of food, water and public health safety.
Keywords
Programme(s)
- HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA) Main Programme
Funding Scheme
HORIZON-TMA-MSCA-DN - HORIZON TMA MSCA Doctoral NetworksCoordinator
1180 Wien
Austria
See on map
Participants (8)
28359 Bremen
See on map
75794 Paris
See on map
14195 Berlin
See on map
75654 Paris
See on map
44307 Nantes
See on map
07747 Jena
See on map
2000 Antwerpen
See on map
751 05 Uppsala
See on map
Partners (14)
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
8008 Zurich
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
86757 Wallerstein
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
95051 Santa Clara
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
12205 Berlin
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
8600 Dübendorf
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
2340 Beerse
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
B 6536 Donstiennes
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
SK9 4AX Wilmslow Cheshire
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
M13 9PL Manchester
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
Participation ended
33000 Bordeaux
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
67081 Strasbourg
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
1211 Geneve
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
34090 Montpellier
See on map